Form 4 for ANIX Anixa Biosciences Inc
Accepted 2024-08-01 00:00:00 ET · period of report 2024-07-30 · accession 0001493152-24-029884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-01 | 2024-07-30+ | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.09 | +27.2K | 890.8K | +3% | +$84.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | P | A | 5,580 | $3.23 | 896,334 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-30 | P | A | 21,646 | $3.06 | 890,754 | D | — | — |